Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
61
CDTX Quote, Financials, Valuation and Earnings
Last price:
$23.11
Seasonality move
:
12.86%
Day range:
$21.20 - $24.00
52-week range:
$10.00 - $24.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.91x
P/B ratio:
2.20x
Volume:
148.4K
Avg. volume:
73.5K
1-year change:
54.8%
Market cap:
$254M
Revenue:
$63.9M
EPS (TTM):
-$25.36
Earnings Data
Next earnings date for CDTX
Apr 22
2025
Most recent earnings per share
-$2.45
Beat by $2.99
(Nov 7/2024)
Consensus Estimate
-$5.44
(Nov 7/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CDTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q4 | $240K | -- | -- | -$3.49 | -- |
| 11/07/2024 | Q3 | $433.3K | -- | -$2.45 | -$5.44 | $2.99 |
| 08/13/2024 | Q2 | $1.3M | $302K | -$19.99 | -$3.15 | -$16.85 |
| 05/15/2024 | Q1 | $9M | $8.5M | -$2.28 | -$2.39 | $0.11 |
| 03/22/2024 | Q4 | $11.5M | $43.4M | -$0.64 | -$2.07 | $1.43 |
| 11/02/2023 | Q3 | $8.1M | $9.2M | -$2.02 | -$3.00 | $0.98 |
| 08/03/2023 | Q2 | $11.5M | $5.1M | -$3.02 | -$2.60 | -$0.42 |
| 05/11/2023 | Q1 | $18.7M | $26.1M | $0.60 | -$0.73 | $1.33 |
| 03/23/2023 | Q4 | $10.6M | $10.4M | -$3.80 | -$2.93 | -$0.87 |
| 11/03/2022 | Q3 | $22.7M | $40.7M | $3.40 | -$0.20 | $3.60 |
| 08/09/2022 | Q2 | -- | $6.2M | -$3.80 | -- | -- |
| 05/11/2022 | Q1 | -- | $7.1M | -$5.40 | -- | -- |
| 03/07/2022 | Q4 | -- | $7.2M | -$5.20 | -- | -- |
| 11/10/2021 | Q3 | -- | $7.1M | -$7.40 | -- | -- |
| 08/12/2021 | Q2 | -- | $32.9M | $3.60 | -- | -- |
| 05/13/2021 | Q1 | -- | $2.4M | -$7.80 | -- | -- |
| 02/25/2021 | Q4 | -- | $3.7M | -$9.80 | -- | -- |
| 11/05/2020 | Q3 | -- | $2.4M | -$8.20 | -- | -- |
| 08/13/2020 | Q2 | -- | $3.4M | -$9.00 | -- | -- |
| 05/13/2020 | Q1 | -- | $2.5M | -$9.20 | -- | -- |
| 03/04/2020 | Q4 | -- | $1.8M | -$8.40 | -- | -- |
| 11/07/2019 | Q3 | -- | $19.1M | $1.60 | -- | -- |
| 08/08/2019 | Q2 | -- | -- | -$9.40 | -- | -- |
| 05/09/2019 | Q1 | -- | -- | -$11.60 | -- | -- |
| 02/28/2019 | Q4 | -- | -- | -$8.80 | -- | -- |
| 11/08/2018 | Q3 | -- | -- | -$9.80 | -- | -- |
| 08/08/2018 | Q2 | -- | -- | -$22.60 | -- | -- |
| 05/10/2018 | Q1 | -- | -- | -$16.00 | -- | -- |
| 02/27/2018 | Q4 | -- | -- | -$13.80 | -- | -- |
| 11/08/2017 | Q3 | -- | -- | -$14.60 | -- | -- |
| 08/09/2017 | Q2 | -- | -- | -$19.80 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$16.00 | -- | -- |
| 03/17/2017 | Q4 | -- | -- | -$17.60 | -- | -- |
| 11/10/2016 | Q3 | -- | -- | -$17.60 | -- | -- |
| 08/11/2016 | Q2 | -- | -- | -$17.00 | -- | -- |
| 05/19/2016 | Q1 | -- | -- | -$14.20 | -- | -- |
| 03/21/2016 | Q4 | -- | -- | -$14.40 | -- | -- |
| 11/17/2015 | Q3 | -- | -- | -$13.40 | -- | -- |
| 08/20/2015 | Q2 | -- | -- | -$11.80 | -- | -- |
| 03/31/2015 | Q1 | -- | -- | -$10.61 | -- | -- |
| 12/31/2014 | Q4 | -- | -- | -$7.32 | -- | -- |
Cidara Therapeutics Earnings Questions
-
How Much did Cidara Therapeutics Generate in Revenue Last Quarter?
Cidara Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Cidara Therapeutics Beat Earnings Last Quarter?
Cidara Therapeutics announced earnings per share of -$2.45 which represents a beat of analyst forecast a -$5.44 per share.
-
Is Cidara Therapeutics Profitable?
Cidara Therapeutics reported $6.9M that represents $1.52 per share over the last quarter.
-
What is the Analyst Consensus for Cidara Therapeutics EPS Next Year?
Cidara Therapeutics's earnings are forecast to decrease from -$5.20 per share to -$6.13 per share next year representing a decrease of -341.73%.
-
When is Cidara Therapeutics's Earnings Date?
Cidara Therapeutics's next earnings date is April 22, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 8.35% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 5.23% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.03% over the past day.
